HIV-specific cytotoxic T-cell responses

摘要

The use of a T-cell inducing HIV derived molecule in a medicine to generate an HIV specific cytotoxic T-cell (CTL) response in a host. The medicine is formulated for separate, sequential or simultaneous administration. The T- helper molecule is selected from the group consisting of DP, DR and DQ-specific t-cell epitopes. The T-helper molecule acts to prime T-helper cells of the immune system of the host before and or during the administration of the medicine.